Graves’ Disease Market to Witness Upsurge in Growth During the Forecast Period 2032, Examine DelveInsight | Key Companies – Apitope, Worg Pharma, Astellas, Viridian, ImmunoGen, AV7, HanAll Biopharma
DelveInsight’s “Graves’ Disease Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Graves’ Disease Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Graves’ Disease market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Graves’ Disease: An Overview
Graves’ Disease is a common form of hyperthyroidism. In this autoimmune disease, the immune system creates antibodies known as thyroid-stimulating immunoglobulins. They then attach to healthy thyroid cells, thus, causing one’s thyroid to create too much thyroid hormone.
According to Graves’ disease and thyroid foundation, Graves’ disease, also known as toxic diffuse goiter, is the most common cause of hyperthyroidism – a disorder that occurs when the thyroid gland makes more thyroid hormone than the body needs.
Graves’ Disease Market Key Facts
-
According to the National Institute of Diabetes and Digestive and Kidney Diseases (n.d.), the disease affects about 1 in 200 people in the United States and is the most common cause of hyperthyroidism.
-
According to Cleveland Clinic (n.d.), Graves’ disease affects one out of every 200 Americans, making it the top cause of hyperthyroidism.
-
As per the National Institute of Diabetes and Digestive and Kidney Diseases, 30 percent of people who develop Graves’ disease will get a mild case of Graves’ ophthalmopathy. Upto 5 percent will get severe Graves’ ophthalmopathy.
-
It is observed that Graves’ Disease is 7-8 times more common in women than men.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Graves’ Disease market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report details the Graves’ Disease market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.
Graves’ Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.
Graves’ Disease Epidemiology Segmentation
-
Total Prevalence of Graves’ Disease
-
Age-specific cases of Graves’ Disease
-
Gender-specific cases of Graves’ Disease
Graves’ Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Graves’ Disease market or expected to get launched during the study period. The analysis covers Graves’ Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Graves’ Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/graves-disease-market
Graves’ Disease Therapeutics Analysis
There are two goals in the treatment of Graves’ disease. One is to stop the thyroid gland from overproducing thyroid hormone. The other is to stop the increased thyroid hormone levels from causing problems in the body. There are several treatment options to achieve one or both of these goals. Several key companies are actively working in the Graves’ Disease Therapeutics market to improve the treatment scenario further.
Some of the companies in the Graves’ Disease Market include:
-
Novartis
-
Apitope
-
Worg Pharmaceuticals
-
Astellas
-
Jiangsu Hengrui Medicine
-
Viridian Therapeutics
-
ImmunoGen
-
AV7
-
HanAll Biopharma
-
Harbour BioMed
-
Immunovant
And others
Graves’ Disease Therapies covered in the report include:
-
Secukinumab
-
ATX-GD-59
-
K1-70
And many more
Get More Detailed Insights Into the Emerging Therapies & Key Companies –
https://www.delveinsight.com/sample-request/graves-disease-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Graves’ Disease Competitive Intelligence Analysis
4. Graves’ Disease Market Overview at a Glance
5. Graves’ Disease Disease Background and Overview
6. Graves’ Disease Patient Journey
7. Graves’ Disease Epidemiology and Patient Population
8. Graves’ Disease Treatment Algorithm, Current Treatment, and Medical Practices
9. Graves’ Disease Unmet Needs
10. Key Endpoints of Graves’ Disease Treatment
11. Graves’ Disease Marketed Products
12. Graves’ Disease Emerging Therapies
13. Graves’ Disease Seven Major Market Analysis
14. Attribute Analysis
15. Graves’ Disease Market Outlook (7 major markets)
16. Graves’ Disease Access and Reimbursement Overview
17. KOL Views on the Graves’ Disease Market.
18. Graves’ Disease Market Drivers
19. Graves’ Disease Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/graves-disease-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
Secondary Hyperparathyroidism Market
“Secondary Hyperparathyroidism Market” research report provides a detailed overview of the historical and forecasted epidemiology as well as the Secondary Hyperparathyroidism Market size, share, and trends in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). Additionally, it also covers the latest innovations, breakthroughs, emerging therapies, and key companies operating in the therapeutics market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
